Detection of medullary thyroid cancer: a focus on serum calcitonin levels

References

• Roman SA, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical and pathologic predictors of survival in 1252 cases. Cancer107(9), 2134–2142 (2006).
   PubMed Web of Science ®Google Scholar
• Massoll N, Mazzaferri EL. Diagnosis and management of medullary thyroid carcinoma. Clin. Lab. Med.24 (1), 49–83 (2004).
   PubMed Web of Science ®Google Scholar
• Machens A, Schneyer U, Holzhausen HJ, Dralle H. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J. Clin. Endocrinol. Metab.90(4), 2029–2034 (2005).
   PubMed Web of Science ®Google Scholar
• Fialkowski EA, Moley JF. Current approaches to medullary thyroid carcinoma, sporadic and familial. J. Surg. Oncol.94(8), 737–747 (2006).
   PubMed Web of Science ®Google Scholar
• You YN, Lakhani V, Wells SA, Moley JF. Medullary thyroid cancer. Surg. Oncol. Clin. North Am.15(3), 639–660 (2006).
   PubMed Web of Science ®Google Scholar
• Boi F, Maurelli I, Pinna G et al. Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma. J. Clin. Endocrinol. Metab.92(6), 2115–2118 (2007).
   PubMed Web of Science ®Google Scholar
• Karges W, Dralle H, Raue F et al. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendations. Exp. Clin. Endocrinol. Diabetes112(1), 52–58 (2004).
   PubMed Web of Science ®Google Scholar
• d’Herbomez M, Caron P, Bauters C et al. Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking. Eur. J. Endocrinol.157(6), 749–755 (2007).
   PubMed Web of Science ®Google Scholar
• Niccoli P, Brunet P, Roubicek C et al. Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis. Eur. J. Endocrinol.132(1), 75–81 (1995).
   PubMed Web of Science ®Google Scholar
• Borchhardt KA, Heinzl H, Gessl A, Horl WH, Kaserer K, Sunder-Plassman G. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia. Kidney Int.70(11), 2014–2020 (2006).
   PubMed Web of Science ®Google Scholar
• Karanikas G, Moameni A, Poetzi C et al. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J. Clin. Endocrinol. Metab.89(2), 515–519 (2004).
   PubMed Web of Science ®Google Scholar
• Vlaeminck-Guillem V, d’Herbomez M, Pigny P et al. Pseudohypoparathyroidism Ia and hypercalcitoninemia. J. Clin. Endocrinol. Metab.86(7), 3091–3096 (2001).
   PubMed Web of Science ®Google Scholar
• Machens A, Haedecke J, Holzhausen JH, Thomusch O, Schneyer U, Dralle H. Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation. Langenbeck’s Arch. Surg.385(6), 398–401 (2000).
   PubMed Web of Science ®Google Scholar
• Scollo C, Baudin E, Travagli JP et al. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J. Clin. Endocrinol. Metab.88(5), 2070–2075 (2003).
   PubMed Web of Science ®Google Scholar
• Tamagnini P, Iacobone M, Sebag F, Marcy M, DeMicco C, Henry JF. Lymph node involvement in macroscopic medullary thyroid carcinoma. Br. J. Surg.92(4), 449–453 (2005).
   PubMed Web of Science ®Google Scholar
• Schlumberger M, Carlomagno F, Baudin E, Bidart JM, Santoro M. New therapeutic approaches to treat medullary thyroid cancer. Nat. Clin. Pract. Endocrinol. Metab.4(1), 22–32 (2008).
   PubMedGoogle Scholar
• Wells S, Gosnell J, Gagel, RF et al. Vandetanib in metastatic hereditary medullary thyroid cancer: follow-up results of an open-label Phase II trial. Am. Soc. Clin. Oncol. (2007) Abstract.
   Google Scholar
• Clark JR, Fridman TR, Odell MJ et al. Prognostic variables and calcitonin in medullary thyroid cancer. Laryngoscope115(8), 1445–1550 (2005).
   PubMed Web of Science ®Google Scholar
• Miccoli P, Minuto MN, Ugolini C et al. Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer. Endocr. Relat. Cancer14(4), 1099–1105 (2007).
   PubMed Web of Science ®Google Scholar
• Pacini F, Schlumberger M, Dralle H et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol.154(6), 787–803 (2006).
   PubMed Web of Science ®Google Scholar
• Cooper DS, Doherty GM, Haugen BR et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Taskforce. Thyroid16(2), 109–142 (2006).
   PubMed Web of Science ®Google Scholar
• Pacini F, Fontanelli M, Fugazzola L et al. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J. Clin. Endocrinol. Metab.78(4), 826–829 (1994).
   PubMed Web of Science ®Google Scholar
• Elisei R, Bottici V, Luchetti F et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J. Clin. Endocrinol. Metab.89(1), 163–168 (2004).
   PubMed Web of Science ®Google Scholar
• Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S. Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid15(11), 1267–1272 (2005).
   PubMed Web of Science ®Google Scholar
• Costante G, Meringolo D, Durante C et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J. Clin. Endocrinol. Metab.92(2), 450–455 (2007).
   PubMed Web of Science ®Google Scholar
• Gimm O. Surgery for medullary thyroid cancer. In: Surgery of the Thyroid and Parathyroid Glands. Oertli D, Udelsman R (Eds). Springer-Verlag, Berlin, Heidelberg, Germany 147–160 (2007).
   Google Scholar
• Redding AH, Levine SN, Fowler MR. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid10(10), 919–922 (2000).
   PubMed Web of Science ®Google Scholar
• Bockhorn M, Frilling A, Rewerk S et al. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. Thyroid14(11), 468–470 (2004).
   PubMed Web of Science ®Google Scholar
• Wang TS, Ocal IT, Sosa JA et al. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma. Thyroid (2007) (In Press).
   Google Scholar
• Iacobone M, Niccoli-Sire P, Sebag F, De Micco C, Henry JF. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. World J. Surg.26(8), 886–890 (2002).
   PubMed Web of Science ®Google Scholar
• Scheuba C, Kaserer K, Weinhäusl A et al. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery126(6), 1089–1096 (1999).
   PubMed Web of Science ®Google Scholar
• Hamy A, Pessaux P, Mirallie E et al. Central neck dissection in the management of sporadic medullary thyroid microcarcinoma. Eur. J. Surg. Oncol.31(7), 774–777 (2005).
   PubMed Web of Science ®Google Scholar
• Scheuba C, Kaserer K, Beiglmayer C et al. Medullary thyroid microcarcinoma recommendations for treatment – a single-center experience. Surgery142(6), 1003–1010 (2007).
   PubMed Web of Science ®Google Scholar
• Borget I, De Pouvourville G, Schlumberger M. Calcitonin determination in patients with nodular thyroid disease. J. Clin. Endocrinol. Metab.92(2), 425–427 (2007).
   PubMed Web of Science ®Google Scholar
• Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA. Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost–effectiveness and decision analysis. J. Clin. Endocrinol. Metab. DOI: 10.1210/jc.2007-2496 (2008) (Epub ahead of print).
   Google Scholar